Side by sideBeOne (6160.HK) and Hansoh (3692.HK)Memos of October 16, 2026 and October 18, 2026
BeOne vs Hansoh stock: the numbers side by side (October 2026)
How do BeOne and Hansoh compare?
| BeOne 6160.HK | Hansoh 3692.HK | |
|---|---|---|
| Revenue growth | 40.2%2025 | 22.6%2025 |
| Free cash flow | 921.741US$ millions · 2025 | 6,359.436RMB millions · 2025 |
| Free cash flow yield | 2.2%Today (Oct 16, 2026) | 3.9%Today (Oct 18, 2026) |
| Dividend yield | 0.0%Today (Oct 16, 2026) | 1.4%Today (Oct 18, 2026) |
| P/E, last 12 months | 66.5xToday (Oct 16, 2026) | 24.6xToday (Oct 18, 2026) |
| P/E, next 12 months | 37.2xToday (Oct 16, 2026) | 23.6xToday (Oct 18, 2026) |
| Weighted price forecast, about 1 year | 278.80 (+24 %)October 2027 | 27.90 (-11 %)October 2027 |
| Weighted price forecast, about 3 years | 335.61 (+50 %)October 2029 | 30.98 (+2 %)October 2029 |
Who leads on what?
| Leads | The lead is | |
|---|---|---|
| Revenue growth | BeOne | The higher figure |
| Free cash flow | — | The higher figure |
| Free cash flow yield | Hansoh | The higher figure |
| Dividend yield | Hansoh | The higher figure |
| P/E, last 12 months | Hansoh | The lower figure |
| P/E, next 12 months | Hansoh | The lower figure |
| Weighted price forecast, about 1 year | BeOne | The higher weighted return |
| Weighted price forecast, about 3 years | BeOne | The higher weighted return |
What does each company do?
BeOne Medicines sells cancer medicines to distributors, pharmacies and hospitals.
BeOne (6160.HK), from our memo of October 16, 2026 · BeOne stock forecast
Hansoh discovers, makes and sells prescription medicines, led by cancer drugs, for patients through hospitals and pharmacies.
Hansoh (3692.HK), from our memo of October 18, 2026 · Hansoh stock forecast